1Li JJ,Fang CH.C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular disease[J].Med Hypotheses,2004,62:499-506.
2Biasucc LM,Liuzzo G,Angiolillo DJ,et al.Inflammation and acute coronary syndromes[J].Herz,2000,25(2):108-112.
4Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C reactive protein and serum amyloid Aprotein in severe unsta ble angina[J]. N Engl J Med, 1994,331:417-424.
5Kantor PF, Lucien A,Kozak R,et al. The antianginal drug trime tazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitoehondrial long chain 3-ketoaeyl eoenzyme A thiolase[J]. Cite Res, 2000,86 (5) : 580-588.
6Kuralay F, Altekin E, Yazlar AS, et al. Suppression of angioplasty-related inflammation by pre-procedural treatment with trimetazidine[J]. Tohoku J Exp Med,2006,208(3) :203-212.
7Williams FM, Tanda K, Kus M, et al. Trimetazidine inhibits neutrophil accumulation after myocardial ischaemia and reperfusion in rabbits[J]. J Cardiovase Pharmacol, 1993,22 : 828-833.
8Tabbi Anneni I, Lueion A, Grynberg A. Trimetazidine effect on phospholipid synthesis in ventricular myocytes: consequences in alpha-adrenergic signaling [J]. Fumdamental&Clinical Pharma- cology,2003,17(1) :51-59.
9Bayram E, Atalay C,Koeaturk H,et al. Effects of trimetazidine on lipid peroxidation,antioxidant enzyme activities and plasma brain natriuretic peptide levels in patients with chronic cor pulmonale [J]. The Journal of International Research, 2005, 33 ( 6 ) : 612- 619.
